In the cohort of 131 patients with CTLA-4 insufficiency, 13% of the affected CTLA4 variant carriers had a malignant cell growth, most frequently EBV-associated lymphomas and gastric cancer.8 The gene discussed is CTLA4; the disease is gastric cancer.